Research
The recombinant protein of DecoDerma is designated as an orphan medicinal product at European Medicine Agency (EMA)
Published on 16.6.2022
Tampere University
DecoDerma recently achieved one of its goals as our recombinant protein received Orphan Drug Designation at EMA.